EC Gastroenterology and Digestive System

Colonic tuberculosis [TB] is a rare entity even in countries with an endemic TB problem. While the current incidence of pulmonary TB is rising in the developed world the incidence of colonic TB has remained extremely rare. The incidence of TB in Canada has been documented at 26 per 100 000 population for Indigenous Canadians and 17 per 100 000 for immigrant Canadians from developing countries. This is in stark contrast to the 4.7 per 100 000 population for the rest of Canada which remains one of the lowest in the world. Manitoba remains the province at highest risk. Risk factors included immunocompromised patients such as HIV patients, geriatric population and intravenous drug users. Colonic TB is rarely diagnosed preoperatively and usually manifests as a surgical complication such as perforation or obstruction. Surgery is often limited to managing the complications of colonic disease. We would like to present our case series of two colonic TB patients, their endoscopic findings and their subsequent successful medical management.

 Keywords: Intestinal Tuberculosis; Colonic Tuberculosis; Extra Pulmonary Tuberculosis

1. Rawla P and Barsouk A. “Epidemiology of gastric cancer: global trends, risk factors and prevention”. Przeglad Gastroenterologiczny 1 (2019): 26-38.
2. Jabłońska B and Mrowiec S. “Gastrointestinal disease: new diagnostic and therapeutic approaches”. Biomedicines5 (2023): 1420.
3. Sipponen P and Maaroos HI. “Chronic gastritis”. Scandinavian Journal of Gastroenterology 6 (2015): 657-67.
4. Zabaleta J. “Multifactorial etiology of gastric cancer”. Methods in Molecular Biology 863 (2012): 411-435.
5. Bacha D., et al. “Chronic gastritis classifications”. La Tunisie Médicale 7 (2018): 405-410.
6. Chen YC., et al. “Global prevalence of Helicobacter pylori infection and incidence of gastric cancer between 1980 and 2022”. Gastroenterology4 (2024): 605-619.
7. Paragomi P., et al. “The association between peptic ulcer disease and gastric cancer: results from the stomach cancer pooling (StoP) project consortium”. Cancers (Basel)19 (2022): 4905.
8. Du S., et al. “Gastric cancer risk of intestinal metaplasia subtypes: a systematic review and meta-analysis of cohort studies”. Clinical and Translational Gastroenterology 10 (2021): e00402.
9. Waldum H and Fossmark R. “Gastritis, gastric polyps and gastric cancer”. International Journal of Molecular Sciences 12 (2021): 6548.
10. Smith J., et al. “Association between chronic gastric reflux and gastric cancer: unraveling the complex relationship”. Journal of Gastrointestinal Oncology3 (2020): 450-465.
11. Jaroenlapnopparat A., et al. “Inflammation and gastric cancer”. Diseases3 (2022): 35.
12. Uson PLS., et al. “Germline cancer testing in unselected patients with gastric and esophageal cancers: a multi-center prospective study”. Digestive Diseases and Sciences 11 (2022): 5107-5115.
13. Ku GY., et al. “Prevalence of germline alterations on targeted tumor-normal sequencing of esophagogastric cancer”. JAMA Network Open 7 (2021): e2114753.
14. Yang J., et al. “Role of the gastric microbiome in gastric cancer: from carcinogenesis to treatment”. Frontiers in Microbiology 12 (2021): 641322.
15. Shah D and Bentrem D. “Environmental and genetic risk factors for gastric cancer”. Journal of Surgical Oncology 7 (2022): 1096-1103.
16. Candelli M and Franceschi F. “New advances in gastroenterology: the crucial role of molecular medicine”. International Journal of Molecular Sciences 19 (2023): 14907.
17. Yuan DD., et al. “Targeted therapy for gastric cancer: Current status and future directions (Review)”. Oncology Reports 3 (2016): 1245-1254.
18. Shi XJ., et al. “Systems biology of gastric cancer: perspectives on the omics-based diagnosis and treatment”. Frontiers in Molecular Biosciences 7 (2020): 203.
19. Zhao K., et al. “Advances in translational therapy for locally advanced gastric cancer”. World Journal of Clinical Cases 11 (2023): 2405-2411.
20. López MJ., et al. “Characteristics of gastric cancer around the world”. Critical Reviews in Oncology/Hematology 181 (2023): 103841.
21. Sharan S., et al. “Time to treatment disparities in gastric cancer patients in the United States of America: a comprehensive retrospective analysis”. Frontiers in Oncology 14 (2024): 1292793.